Investment Summary

General Atlantic Invests In Biofourmis

On April 26, 2022, growth capital firm General Atlantic invested in software company Biofourmis

Investment Highlights
  • This is General Atlantic’s 25th transaction in the Software sector.
  • This is General Atlantic’s 153rd transaction in the United States.
  • This is General Atlantic’s 15th transaction in Massachusetts.

Investment Summary

Date 2022-04-26
Target Biofourmis
Sector Software
Investor(s) General Atlantic
Deal Type Growth Capital

Target

Biofourmis

Boston, Massachusetts, United States
Biofourmis discovers, develops and delivers clinically validated software-based therapeutics to provide better outcomes for patients, advanced tools for clinicians to deliver personalized care, technology to demonstrate the value of and potentially complement pharmacotherapy, and cost-effective solutions for payers. Biofourmis was founded in 2015 and is based in Boston, Massachusetts.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

General Atlantic

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1980
PE ASSETS 73.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

General Atlantic is a large private equity firm that invests globally in growth-oriented public and private companies. Broad areas of interest include financial services, media and consumer, healthcare, enterprise solutions, communications and electronics, and energy. General Atlantic looks to invest $40 to $400 million in transactions that support growth, expansions, buy-outs, consolidations and build-ups. General Atlantic seeks to make 8 to 12 investments per year with an investment horizon of five to ten years. The Firm's geographic coverage spans North America; Europe; Asia/Pacific; and India. General Atlantic was formed in 1980 and is based in Greenwich, Connecticut.


DEAL STATS #
Overall 319 of 343
Sector (Software) 25 of 27
Type (Growth Capital) 124 of 129
State (Massachusetts) 15 of 17
Country (United States) 153 of 163
Year (2022) 13 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-19 ThreatLocker

Orlando, Florida, United States

ThreatLocker is a global cybersecurity company, providing enterprise-level cybersecurity tools to improve the security of servers and endpoints. ThreatLocker was founded in 2017 and is based in Orlando, Florida.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-05 Pantherx

Pittsburgh, Pennsylvania, United States

Pantherx is a rare disease pharmacy, comprehensively serving patients afflicted with rare and devastating conditions through the delivery of medical breakthroughs, clinical excellence, and access solutions. Pantherx offers a suite of synchronized compliance, logistics, and analytics solutions to help streamline the process of delivering orphan medications and care to people living with complicated rare diseases. Pantherx was founded in 2011 and is based in Pittsburgh, Pennsylvania.

Buy -